Fistulizing Crohn's disease.
| Data(s) |
2005
|
|---|---|
| Resumo |
Fistulas are common in Crohn's disease. A population-based study has shown a cumulative risk of 33% after 10 years and 50% after 20 years. Perianal fistulas were the most common (54%). Medical therapy is the main option for perianal fistula once abscesses, if present, have been drained, and should include antibiotics (both ciprofloxacin and metronidazole) and immunomodulators. Infliximab should be reserved for refractory patients. Surgery is often necessary for internal fistulas. |
| Identificador |
http://serval.unil.ch/?id=serval:BIB_F5B981CC3864 isbn:0012-2823 pmid:15711045 doi:10.1159/000083868 isiid:000227888500006 |
| Idioma(s) |
en |
| Fonte |
Digestion, vol. 71, no. 1, pp. 26-28 |
| Palavras-Chave | #Anti-Bacterial Agents; Clinical Trials as Topic; Crohn Disease; Digestive System Surgical Procedures; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Proctocolitis; Rectal Fistula; Treatment Outcome |
| Tipo |
info:eu-repo/semantics/review article |
